18 patients treated at a specialized consultation centre for disorders of fat metabolism were administered a new-generation hypolipidemic ( preparation lovastatin-mevacor ) produced by merck sharp and dohme , which inhibits intracellular synthesis of cholesterol .
C0024027
lovastatin
C0728780
mevacor